Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706992200 on January 7, 2008

J. Biol. Chem., Vol. 283, Issue 11, 7007-7015, March 14, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/11/7007    most recent
M706992200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Pestell, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Pestell, R. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration*Formula

Zhiping Li{ddagger}, Chenguang Wang{ddagger}1, Xuanmao Jiao{ddagger}, Sanjay Katiyar{ddagger}, Mathew C. Casimiro{ddagger}, George C. Prendergast§, Michael J. Powell{ddagger}, and Richard G. Pestell{ddagger}2

From the {ddagger}Kimmel Cancer Center, Departments of Cancer Biology and Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and §Lankenau Institute for Medical Research, Wynnewood, Pennsylvania 19096

Cyclin D1 is an important cell cycle regulator, but in cancer its overexpression also increases cellular migration mediated by p27KIP1 stabilization and RhoA inhibition. Recently, a common polymorphism at the exon 4-intron 4 boundary of the human cyclin D1 gene within a splice donor region was associated with an altered risk of developing cancer. Altered RNA splicing caused by this polymorphism gives rise to a variant cyclin D1 isoform termed cyclin D1b, which has the same N terminus as the canonical cyclin D1a isoform but a distinct C terminus. In this study we show that these different isoforms have unique properties with regard to the cellular migration function of cyclin D1. Although they displayed little difference in transcriptional co-repression assays on idealized reporter genes, microarray cDNA expression analysis revealed differential regulation of genes, including those that influence cellular migration. Additionally, whereas cyclin D1a stabilized p27KIP1 and inhibited RhoA-induced ROCK kinase activity, promoting cellular migration, cyclin D1b failed to stabilize p27KIP1 or inhibit ROCK kinase activity and had no effect on migration. Our findings argue that alternate splicing is an important determinant of the function of cyclin D1 in cellular migration.


Received for publication, August 21, 2007 , and in revised form, January 4, 2008.

* This work was supported by National Institutes of Health Grants R01CA70896, R01CA75503, R01CA86072 (to R. G. P.) and the Susan Komen Breast Cancer Foundation Grant BCTR0504227 (to C. W.). This project is funded in part from the Dr. Ralph and Marian C. Falk Medical Research Trust (to R. G. P.) and grants from Pennsylvania Department of Health (to R. G. P. and C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables 1 and 2 and data 3.

1 To whom correspondence may be addressed. Tel.: 215-503-9341; Fax: 215-923-4498; E-mail: chenguang.wang{at}jefferson.edu. 2 To whom correspondence may be addressed: Depts. of Cancer Biology and Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th St., Bluemle Life Sciences Bldg., Rm. 1050, Philadelphia, PA 19107. Tel.: 215-503-5649; Fax: 215-923-9334; E-mail: Richard.Pestell{at}jefferson.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
I. Mercier, M. C. Casimiro, J. Zhou, C. Wang, C. Plymire, K. G. Bryant, K. M. Daumer, F. Sotgia, G. Bonuccelli, A. K. Witkiewicz, et al.
Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions
Am. J. Pathol., April 1, 2009; 174(4): 1172 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Sotgia, F. Del Galdo, M. C. Casimiro, G. Bonuccelli, I. Mercier, D. Whitaker-Menezes, K. M. Daumer, J. Zhou, C. Wang, S. Katiyar, et al.
Caveolin-1-/- Null Mammary Stromal Fibroblasts Share Characteristics with Human Breast Cancer-Associated Fibroblasts
Am. J. Pathol., March 1, 2009; 174(3): 746 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Sotgia, M. C. Casimiro, G. Bonuccelli, M. Liu, D. Whitaker-Menezes, O. Er, K. M. Daumer, I. Mercier, A. K. Witkiewicz, C. Minetti, et al.
Loss of Caveolin-3 Induces a Lactogenic Microenvironment that Is Protective Against Mammary Tumor Formation
Am. J. Pathol., February 1, 2009; 174(2): 613 - 629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement